Rankings
▼
Calendar
HROW Q3 2016 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena
HROW
Harrow Health, Inc.
$1B
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$5M
Gross Profit
$3M
51.9% margin
Operating Income
-$5M
-94.9% margin
Net Income
-$4M
-79.2% margin
EPS (Diluted)
$-0.29
QoQ Revenue Growth
-0.9%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$5M
Stock-Based Comp.
$764,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$19M
Stockholders' Equity
$3M
Cash & Equivalents
$2M
← FY 2016
All Quarters
Q4 2016 →